Education
About Us
Working with TipRanks
Follow Us
U.s. Physical Therapy (USPH)
NYSE:USPH
USPH Stock Chart & Stats
$82.12
$0.25(0.28%)
At close: 4:00 PM EST
$82.12
$0.25(0.28%)
Day’s Range― - ―
52-Week Range$62.77 - $93.50
Previous CloseN/A
Volume11.83K
Average Volume (3M)207.51K
Market Cap
$1.26B
Enterprise Value$1.65B
Total Cash (Recent Filing)$35.57M
Total Debt (Recent Filing)$425.74M
Price to Earnings (P/E)58.4
Beta1.15
Next Earnings
Apr 30, 2026EPS Estimate
0.54Next Dividend Ex-DateN/A
Dividend Yield2.25%
Share Statistics
EPS (TTM)0.67
Shares Outstanding15,122,562
10 Day Avg. Volume209,781
30 Day Avg. Volume207,506
Financial Highlights & Ratios
PEG Ratio-3.45
Price to Book (P/B)2.49
Price to Sales (P/S)1.52
P/FCF Ratio19.43
Enterprise Value/Market Cap1.32
Enterprise Value/Revenue2.42
Enterprise Value/Gross Profit10.91
Enterprise Value/Ebitda15.07
Forecast
1Y Price Target
$100.50Price Target Upside22.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)3
Revenue Forecast (FY)$830.45M
Bulls Say, Bears Say
Bulls Say
Margins And ProfitabilityAnalyst points to Medicare rate improvements, productivity gains, and a healthier payer mix as factors that should expand margins and boost adjusted operating profit.
Revenue And Patient VolumeAnalyst highlights accelerating same-store revenues driven by higher patient visit volumes, signaling resilient clinic demand that supports revenue growth expectations.
Strategic Partnerships And AcquisitionsAnalyst expects exclusive hospital affiliation agreements and a recent acquisition to increase referral flows and cross‑sell opportunities, enhancing EBITDA contribution and revenue diversification.
Bears Say
Home-care Concentration And Stock VolatilityAnalyst warns that home‑care expansion faces replication challenges due to concentration in high‑cost regions, and the aggressive risk classification implies potential for greater share price swings.
Leadership UncertaintyAnalyst flags the CFO resignation and appointment of an interim finance chief as a source of leadership uncertainty that could pressure financial execution and investor confidence.
Segment UnderperformanceAnalyst notes the industrial injury prevention business stalled and slightly missed expectations, representing a pocket of weakness that could constrain overall growth momentum.
US Physical Therapy News
USPH FAQ
What was U.s. Physical Therapy’s price range in the past 12 months?
U.s. Physical Therapy lowest stock price was $62.77 and its highest was $93.50 in the past 12 months.
What is U.s. Physical Therapy’s market cap?
U.s. Physical Therapy’s market cap is $1.26B.
When is U.s. Physical Therapy’s upcoming earnings report date?
U.s. Physical Therapy’s upcoming earnings report date is Apr 30, 2026 which is in 57 days.
How were U.s. Physical Therapy’s earnings last quarter?
U.s. Physical Therapy released its earnings results on Feb 25, 2026. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.675 by -$0.005.
Is U.s. Physical Therapy overvalued?
According to Wall Street analysts U.s. Physical Therapy’s price is currently Undervalued.
Does U.s. Physical Therapy pay dividends?
U.s. Physical Therapy pays a Quarterly dividend of $0.45 which represents an annual dividend yield of 2.25%. See more information on U.s. Physical Therapy dividends here
What is U.s. Physical Therapy’s EPS estimate?
U.s. Physical Therapy’s EPS estimate is 0.54.
How many shares outstanding does U.s. Physical Therapy have?
U.s. Physical Therapy has 15,122,562 shares outstanding.
What happened to U.s. Physical Therapy’s price movement after its last earnings report?
U.s. Physical Therapy reported an EPS of $0.67 in its last earnings report, missing expectations of $0.675. Following the earnings report the stock price went down -2.865%.
Which hedge fund is a major shareholder of U.s. Physical Therapy?
Currently, no hedge funds are holding shares in USPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
US Physical Therapy Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$100.50 (22.38% Upside)
$100.50 (22.38% Upside)
Blogger Sentiment
Bearish
USPH Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 68.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.25%
12-Months-Change
Fundamentals
Return on Equity
4.45%
Trailing 12-Months
Asset Growth
2.49%
Trailing 12-Months
Company Description
U.s. Physical Therapy
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
USPH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted strong operational momentum: record visits per clinic, robust revenue growth (PT +17.3%, IIP +22.6%), margin expansion (PT margin to 21.1%), and higher adjusted EBITDA with raised full-year guidance. The company successfully managed costs (salaries per visit +0.7%; total operating cost per visit down), realized acquisition synergies (Metro), and is growing new revenue streams (home care, cash-based services). Key headwinds persist—most notably multi-year Medicare reimbursement reductions (aggregate ~$25M profit impact), a payer policy change in Michigan, staffing tightness in some markets, and ongoing implementation and working-capital considerations. However, management demonstrated execution on growth, cost containment, and strategic initiatives and increased guidance, indicating confidence in continued momentum.View all USPH earnings summariesUSPH Stock 12 Month Forecast
Average Price Target
$100.50
▲(22.38% Upside)
Technical Analysis
AMN Healthcare Services
―
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
Pennant Group
―
Ownership Overview
1.90% Insiders
30.91% Mutual Funds
35.59% Other Institutional Investors
6.20% Public Companies and
Individual Investors